Cardinal Health (CAH)
(Delayed Data from NYSE)
$190.77 USD
+0.93 (0.49%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $190.82 +0.05 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CAH 190.77 +0.93(0.49%)
Will CAH be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for CAH
4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks
Company News for Oct 31, 2025
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics
Cardinal Health (CAH) Surpasses Q1 Earnings and Revenue Estimates
Other News for CAH
Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus
Best Dividend Aristocrats For November 2025
Is CAH building bullish momentum? New 52 Week Closing High shows up after climbing 0.49%
Cardinal Health Reports Strong Revenue Growth in Latest Quarter
CAH: UBS Raises Price Target and Maintains Buy Rating | CAH Stock News